Arax Advisory Partners’s Biote BTMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.81K Sell
3,147
-2,267
-42% -$4K ﹤0.01% 4760
2026
Q2
$10.2K Buy
+5,414
New +$11.2K ﹤0.01% 4324
2025
Q4
– Sell
-1,101
Closed -$3.3K – 4138
2025
Q3
$3.3K Buy
+1,101
New +$3.93K ﹤0.01% 2988
2025
Q1
– Sell
-1
Closed -$7 – 2712
2024
Q4
$7 Hold
1
– – ﹤0.01% 2412
2024
Q3
$6 Hold
1
– – ﹤0.01% 2609
2024
Q2
$8 Buy
+1
New +$6 ﹤0.01% 2532

Other funds holding BTMD

Arax Advisory Partners's BTMD Position: Q3 2026 in Review

Arax Advisory Partners reduced its Biote (BTMD) stake by 42% in Q3 2026, selling an estimated $4K and leaving 3,147 shares worth $3.81K. The position accounts for ﹤0.01% of the portfolio, ranked #4760.

Arax Advisory Partners first reported a position in BTMD in Q2 2024 and has held it in 6 quarters since. The position peaked at $10.2K in Q2 2026. 56 funds tracked by Wall St. Rank hold BTMD as of Q3 2026.

  • Arax Advisory Partners held 3,147 shares of Biote worth $3.81K as of Q3 2026.
  • Arax Advisory Partners sold 2,267 Biote shares in Q3 2026, an estimated $4K.
  • Biote made up ﹤0.01% of Arax Advisory Partners's portfolio in Q3 2026, its #4760 holding.
  • Arax Advisory Partners first reported a position in Biote in Q2 2024 and has held it in 6 quarters since.
  • Arax Advisory Partners's Biote position peaked at $10.2K in Q2 2026.
  • 56 funds tracked by Wall St. Rank held Biote as of Q3 2026.

Based on Arax Advisory Partners's 13F filing for Q3 2026, filed 12 Nov 2026.